Our Business Model

Motega’s business model is to continue to develop advanced delivery and efficacy methodologies, partner with manufacturers and distributors, and commercialize new products by licensing the technology or product to industry sales leaders. It is well documented that one of the most common and challenging issues with traditional drug or therapeutic delivery methods, whether self or practitioner-administered, is complying with the treatment protocol. Compliance for even some life-saving drugs is tragically low. Treatments can be inconvenient, time-consuming, uncomfortable, or even painful – especially for those who hate or have a fear of needles. These circumstances may lead to avoiding, abandoning, or interrupting treatments.